This collaboration combines Organon’s commercial agility with Daiichi Sankyo’s expertise in cardiovascular innovation to bring Nilemdo to patients in France, Denmark, Iceland, Sweden, Finland and Norway
The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Subscribe To Our Newsletter & Stay Updated
